Private · Company · Aksjeselskap

Sarsia Seed AS

990 118 434 ↗Other investment companies, except captive companies · NACE 64.312Bergen

ActiveRegistered 2006Fund · controls 2 companiesSimilar companies →

Status

● Active

Founded

2006

Operating result

kr -3.07M

End-investments

1 company

↳ Brreg · companies

Portfolio · resolved to end-investments

Show flat list

Ownership followed through every holdco layer — you land on the operating company, not the shell. Effective stake = product along the chain.

CompanyStakeRevenueResultEmpLast event

APIM THERAPEUTICS AS

21.4%kr 0kr -8.85M—

Registry · 2026-08-04

Aksjonærregisteret edges · portfolio_edges · latest cap table

■ end-investment — an operating company● pass-through holdcoeffective stake = product along the chain

Portfolio timeline1 companies

APIM THERAPEUTICS AS — capital_change: share_capital2265695 -> 7265695Registry · 2026-08-04

APIM THERAPEUTICS AS — capital_change: number_of_shares2265695 -> 7265695Registry · 2026-08-04

APIM THERAPEUTICS AS — accounts_filed: last_annual_accounts_year2024 -> 2025Registry · 2026-07-27

APIM THERAPEUTICS AS — Audit opinionDeloitte AS issued an unmodified audit opinion stating the financial statements comply with statutory requirements. — oppfyller arsregnsk...Annual report · 2025-12-31

APIM THERAPEUTICS AS — Audit opinionThe audit was carried out in accordance with the International Standards on Auditing. — Vihar gjennomfort revisjonenisamsvarmed Internati...Annual report · 2025-12-31

APIM THERAPEUTICS AS — Staff numbersThe company employed 1.00 man-year during the financial year. — Antall arsverk i regnskapsaretAnnual report · 2025-12-31

APIM THERAPEUTICS AS — RemunerationSalaries were NOK 659 758 in 2025 against NOK 1 175 092 in 2024, with total payroll costs of NOK 770 112. — Lonn 659758.00 1175092.00Annual report · 2025-12-31

APIM THERAPEUTICS AS — Share capitalShare capital consists of 2 265 695 ordinary shares of NOK 1 each, total NOK 2 265 695. — Totalt antall aksjer 2 265 695 100Annual report · 2025-12-31

APIM THERAPEUTICS AS — OwnershipSarsia Seed AS holds 21,41 % and Investor Direkte AS 15,00 % of the shares. — Sarsia Seed AS Investor Direkte AS 485 067 339 860 21,4...Annual report · 2025-12-31

APIM THERAPEUTICS AS — Loan or financing440 772 subscription rights have been issued, each giving the right to subscribe one share at NOK 15, for capital raising to support cont...Annual report · 2025-12-31

APIM THERAPEUTICS AS — ImpairmentNo write-down of financial assets in 2025, against NOK 33 540 409 in 2024. — Nedskrivning av finansielle eiendeler 0 33 540 409Annual report · 2025-12-31

APIM THERAPEUTICS AS — Capitalised R&DOwn research and development costs are expensed as incurred, not capitalised. — Egneforsknings-og utviklingskostnaderkostnadsforesIopende.Annual report · 2025-12-31

APIM THERAPEUTICS AS — ImpairmentPatents constituting the platform technology are carried at cost and not amortised, but the book value is tested for indications of impai...Annual report · 2025-12-31

APIM THERAPEUTICS AS — Deferred taxNo deferred tax asset is recognised; deferred tax at 22 % is calculated to zero as tax-reducing differences cannot be offset. — Utsatt sk...Annual report · 2025-12-31

APIM THERAPEUTICS AS — OtherWithheld payroll tax exceeded the tax-withholding account balance at year end; the remainder was deposited early in January 2026. — Restb...Annual report · 2025-12-31

APIM THERAPEUTICS AS — OtherThe company's business is development, production and marketing/sale of pharmaceutical products, and it is located in Trondheim. — samt a...Annual report · 2025-12-31

APIM THERAPEUTICS AS — STIFTELSEN UNIVERSITETSFORSKNING BERGEN acquired 6.5 pctNew owner · 2025-12-31

APIM THERAPEUTICS AS — NORSK INNOVASJONSKAPITAL III AS exited (held 15.5 pct)Owner exit · 2023-12-31

APIM THERAPEUTICS AS — INVESTINOR AS exited (held 6.3 pct)Owner exit · 2022-12-31

APIM THERAPEUTICS AS — INVESTINOR AS acquired 6.3 pctNew owner · 2021-12-31

Skiwo · company_events